Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: BIOFORCE NANOSCIENCES HOLDINGS, INC.
CIK: 1310488
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2018-10-24
Last Filing Date: 2025-05-13
SEC Filings
Start End Frame Filed ACCN Value View
2021-01-01 2021-03-31 CY2021Q1 2021-04-27 0001091818-21-000055 $ 29,271,756 View
2021-04-01 2021-06-30 None 2021-07-29 0001091818-21-000099 $ 29,271,755 View
2021-04-01 2021-06-30 CY2021Q2 2021-07-30 0001091818-21-000101 $ 29,271,755 View
2021-07-01 2021-09-30 CY2021Q3 2021-10-28 0001091818-21-000138 $ 29,271,755 View
2021-01-01 2021-12-31 CY2020 2022-02-11 0001091818-22-000014 $ -28,760 View
2018-07-01 2018-09-30 CY2017Q3 2018-10-24 0001091818-18-000190 $ 76,302,299 View
2018-01-01 2018-12-31 CY2017 2019-03-29 0001091818-19-000088 $ 76,300,252 View
2019-01-01 2019-03-31 CY2018Q1 2019-04-30 0001091818-19-000131 $ 76,312,031 View
2019-04-01 2019-06-30 CY2018Q2 2019-07-22 0001091818-19-000192 $ 76,314,719 View
2019-07-01 2019-09-30 CY2018Q3 2019-11-05 0001091818-19-000265 $ 76,327,316 View
2019-01-01 2019-12-31 None 2020-03-04 0001091818-20-000036 $ 15,264,706 View
2019-01-01 2019-12-31 CY2018 2020-03-09 0001091818-20-000039 $ 15,264,706 View
2020-01-01 2020-03-31 CY2019Q1 2020-05-04 0001091818-20-000107 $ 15,271,047 View
2020-04-01 2020-06-30 CY2019Q2 2020-07-22 0001091818-20-000170 $ 15,271,755 View
2020-07-01 2020-09-30 CY2019Q3 2020-10-23 0001091818-20-000228 $ 15,271,756 View
2020-01-01 2020-12-31 CY2019 2021-02-16 0001091818-21-000016 $ 16,304,367 View
2023-01-01 2023-03-31 CY2022Q1I 2023-05-09 0001091818-23-000071 $ 686 View
2022-01-01 2022-03-31 None 2022-05-05 0001091818-22-000041 $ 0 View
2022-01-01 2022-03-31 CY2022Q1 2022-05-05 0001091818-22-000045 $ 0 View
2022-04-01 2022-06-30 CY2021Q2 2022-07-27 0001091818-22-000097 $ 29,271,755 View
2022-01-01 2022-12-31 CY2020Q4I 2023-03-28 0001091818-23-000044 $ 100 View
2022-07-01 2022-09-30 CY2021Q3 2022-11-02 0001091818-22-000145 $ 29,271,755 View
2023-01-01 2023-12-31 CY2022 2024-04-01 0001091818-24-000034 $ 29,271,755 View
2024-01-01 2024-12-31 CY2024 2025-04-08 0001091818-25-000036 $ 29,271,755 View
2020-05-01 2020-05-06 CY2022Q2 2023-08-01 0001091818-23-000146 $ 100,000 View
2022-07-01 2022-09-30 CY2022Q3 2023-11-03 0001091818-23-000181 $ 100 View
2024-01-01 2024-03-31 CY2023Q1 2024-05-03 0001091818-24-000049 $ 17,583 View
2024-01-01 2024-06-30 CY2024Q2 2024-08-07 0001091818-24-000085 $ 30,927 View
2024-01-01 2024-09-30 CY2024Q3 2024-11-08 0001091818-24-000134 $ 39,338 View
2025-01-02 2025-01-24 CY2024Q4I 2025-05-13 0001091818-25-000053 $ 4,250,000 View
SEC Facts By Type
Type Name Description View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
us-gaap Compensation Expense, Excluding Cost of Good and Service Sold Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Operating Loss Carryforwards, Valuation Allowance The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. View
us-gaap Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap Accrued Salaries Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes effect from exchange rate changes. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Conversion of Stock, Shares Issued "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period. View
us-gaap Current Income Tax Expense (Benefit) Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Due from Banks A bank's noninterest bearing demand deposits in other banks (such as correspondents). View
us-gaap Due to Related Parties, Current Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. View
us-gaap Increase (Decrease) in Accrued Salaries The increase (decrease) during the period in accrued salaries. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Payments to Acquire Businesses, Gross The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Contributed Capital The cash inflow associated with the amount received by a corporation from a shareholder during the period. View
us-gaap Proceeds from Other Equity Amount of cash inflow from the issuance of equity classified as other. View
us-gaap Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Shares Issued, Price Per Share Per share or per unit amount of equity securities issued. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Stock Issued During Period, Value, Conversion of Units Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Stock Issued During Period, Shares, Acquisitions Number of shares of stock issued during the period pursuant to acquisitions. View
us-gaap Proceeds from Contributions from Parent The cash inflow from parent as a source of financing that is recorded as additional paid in capital. View
us-gaap Stock Issued During Period, Value, Employee Benefit Plan Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan. View
us-gaap Other Expenses Amount of expense classified as other. View
Chart of Accounts => Accounts
Name View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Weighted Average Number of Shares Outstanding, Basic View
Gain (Loss) on Extinguishment of Debt View
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings View
Accounts Payable and Accrued Liabilities, Current View
Accounts Receivable, after Allowance for Credit Loss, Current View
Accrued Salaries View
Additional Paid in Capital, Common Stock View
Assets View
Assets, Current View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Compensation Expense, Excluding Cost of Good and Service Sold View
Conversion of Stock, Shares Issued View
Cost of Revenue View
Current Income Tax Expense (Benefit) View
Deferred Tax Assets, Net of Valuation Allowance View
Due from Banks View
Due to Related Parties, Current View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, Percent View
General and Administrative Expense View
Gross Profit View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Income Tax Expense (Benefit) View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Accounts Receivable View
Increase (Decrease) in Accrued Salaries View
Increase (Decrease) in Prepaid Expense View
Issuance of Stock and Warrants for Services or Claims View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Operating Expenses View
Operating Income (Loss) View
Operating Loss Carryforwards, Valuation Allowance View
Payments to Acquire Businesses, Gross View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Prepaid Expense, Current View
Proceeds from Contributed Capital View
Proceeds from Other Equity View
Proceeds from Related Party Debt View
Retained Earnings (Accumulated Deficit) View
Revenues View
Share-based Payment Arrangement, Noncash Expense View
Shares Issued, Price Per Share View
Stockholders' Equity Attributable to Parent View
Stock Issued During Period, Value, Issued for Services View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Earnings Per Share, Basic View
Earnings Per Share, Diluted View
Stock Issued During Period, Value, Conversion of Units View
Weighted Average Number of Shares Outstanding, Diluted View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Stock Issued During Period, Shares, Acquisitions View
Proceeds from Contributions from Parent View
Stock Issued During Period, Value, Employee Benefit Plan View
Other Expenses View